Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 4756 AL 4770

Research progress on anti-tumor drug resistance of pyridazine-containing structural compounds

Liu YL, Li BQ, Zhang LL, Chen SS, Xi YP, Zhang D, Li HL, Zhou WJ, Ma LY.

Bioorg Med Chem. 2025 Dec 15;131:118420. doi: 10.1016/j.bmc.2025.118420. Epub 2025 Sep 25.

Parkinson disease is a fatty acidopathy

Fanning S, Selkoe D.

Nat Rev Neurol. 2025 Nov;21(11):642-655. doi: 10.1038/s41582-025-01142-2. Epub 2025 Oct 1.

Direct-to-unit, single-visit, curative-intent online adaptive stereotactic ablative radiotherapy for early-stage lung adenocarcinoma

Forghani F, Kiser K, Laugeman E, Hao Y, Beckert R, Rolfingsmeier J, Robinson C, Mazur T, Samson P.

Radiat Oncol. 2025 Oct 1;20(1):148. doi: 10.1186/s13014-025-02700-0.

Pharmacological Diversity of Flavonoids and Their Clinical Application Prospects in Neurological Disorders

Cheng S, Gao H, Yang Y, Zhang M, Wang J, Li N, Ji Y, Wang H, Zhou Y.

Phytother Res. 2025 Nov;39(11):5222-5248. doi: 10.1002/ptr.70097. Epub 2025 Oct 1.

Microglia-associated research in Parkinson's disease: a bibliometric analysis

Chen YJ, Xie MR, Zhou SQ, Liu F.

Front Aging Neurosci. 2025 Sep 16;17:1657349. doi: 10.3389/fnagi.2025.1657349. eCollection 2025.

Changes in Visual Evoked Potential and Optical Coherence Tomography in Parkinson's Disease: A Systematic Review and Meta-Analysis

Hemmatian Z, Heravian Shandiz J, Shoeibi A, Shoeibi N, Shariati R, Haghighi B, Fereydouni F, Yazdani N.

Parkinsons Dis. 2025 Sep 23;2025:2386302. doi: 10.1155/padi/2386302. eCollection 2025.

Corrigendum: Association between freezing of gait and anticipatory postural adjustments in Parkinson's disease

J Phys Ther Sci. 2025 Oct;37(10):550. doi: 10.1589/jpts.36.667c. Epub 2025 Oct 1.

Microbiota-derived aromatic amino acid decarboxylases: linking microbial fitness and host neurochemical communication

Rahmdel S, Luqman A, Götz F.

mBio. 2025 Nov 12;16(11):e0205225. doi: 10.1128/mbio.02052-25. Epub 2025 Oct 2.

Boswellic acids as an adjunct therapy in Parkinson's disease: a double-blind clinical trial investigating on its effects on motor symptoms and inflammatory markers

Shateri S, Khatami SH, Ehtiati S, Talebzadeh MR, Nikakhtar S, Parvar MH, Hosseini SO, Shahidi G, Habibi AH, Salmani F, Namvarjah F, Riazi A, Tafakhori A, Karima S.

Inflammopharmacology. 2025 Nov;33(11):6791-6803. doi: 10.1007/s10787-025-01950-4. Epub 2025 Oct 2.

Bifunctional chitosan-based nanocarriers as promising therapeutic approach for brain disease therapy: A critical review focusing on multiple sclerosis over emerging strategies, technologies and applications

Naghib SM, Khorasani MA, Sharifianjazi F, Tavamaishvili K.

Int J Biol Macromol. 2025 Nov;330(Pt 3):148003. doi: 10.1016/j.ijbiomac.2025.148003. Epub 2025 Sep 30.

Mechanisms of inequitable access to parkinson's disease care: a critical interpretive synthesis

Koehn S, Drummond N, Jasper L, Pham AN, Leung K, Cloutier D, Wieler M, Jones CA.

Int J Equity Health. 2025 Oct 2;24(1):250. doi: 10.1186/s12939-025-02538-8.

The need for developing consensus-based guidelines in assessing Parkinson's disease laterality

Houston E, Boyd S, Iyer V, Boyd J, Gupta D.

Parkinsonism Relat Disord. 2025 Nov;140:108067. doi: 10.1016/j.parkreldis.2025.108067. Epub 2025 Sep 28.

Transcranial Direct Current Stimulation in Parkinson's Disease Patients in the Off State: A Randomized Controlled Crossover Trial Examining the Effects on Pain With and Without the Influence of Dopaminergic Medication

González-Zamorano Y, Moreno-Verdú M, Martínez-Benito A, Fernández-Carnero J, Romero JP.

Pain Pract. 2025 Nov;25(8):e70082. doi: 10.1111/papr.70082.

Integrative analysis reveals generalizable human neurodegenerative disease-associated glial states

Horan-Portelance L, Acri DJ, Mann A, Brooks J, Bailey HM, Gibbs JR, DeCasien AR, Cookson MR.

bioRxiv [Preprint]. 2025 Sep 25:2025.09.25.678630. doi: 10.1101/2025.09.25.678630.

Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removal

Cotton MW, Venkatesan S, Beckwith JS, Böken D, Xu CK, Fertan E, Breiter JC, Berkowicz LE, Salazar LS, Von Schulze A, Andrzejewska EA, Brock EE, Han HL, Schneider MM, Sahtoe DD, Baker D, Rowe JB, Goriely A, McEwan WA, Knowles TPJ, Lee SF, Halfmann R, Klenerman D, Meisl G.

bioRxiv [Preprint]. 2025 Oct 30:2025.09.08.674880. doi: 10.1101/2025.09.08.674880.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias